Tandem Diabetes Care Inc Insiders are Selling. Investors Should Take Notice

GuruFocus data shows that Elizabeth Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care Inc ( NA:TNDM), sold 1,084 shares on December 27, 2021.

Tandem Diabetes Care Inc Insiders are Selling. Investors Should Take Notice
Tandem Diabetes Care Inc Insiders are Selling. Investors Should Take Notice

Insiders selling shares can cause investors concern. This could indicate that insiders have become bearish about the shares of their company's stock. Investors should pay close attention to insiders' ability to determine the company's value. We'll take a closer look at Tandem Diabetes Care Inc's insider sale to determine if investors should be skeptical.

Elizabeth Gasser trades

Elizabeth Gasser sold 23,952 shares over the last year.

Elizabeth Gasser may have been selling the stock of their company for a long time. Contrary to what was expected, this could be a good sign for stock. Insiders selling frequently could indicate that their company has a large number of stock options for executives. Executives will sell some shares to raise cash. It is possible, however, that insiders became more bearish about the stock. Insider selling should not be taken lightly by investors.

Trends from the inside

One insider selling doesn't necessarily mean other insiders have a bearish view of the stock. Is the stock being sold by other insiders? Or have top company executives and owners bought more recently?

Tandem Diabetes Care Inc's insider transactions history shows that there were 0 insider buys over the last year. During the same period, 45 insider sales were made.

Elizabeth Gasser isn't the only insider who has sold shares in recent months; there are other insiders of companies that have been buying more than selling, which can be troubling for investors. We should remember that insiders can sell shares for different reasons. A high level of insider sales could indicate a negative sign or neutral, depending upon the motivation behind it.

Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at editors@gurufocus.com!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

This article first appeared on GuruFocus.